TFRC and Alzheimer disease: Transferrin receptor, which facilitates brain iron uptake, was also significantly increased in the plasma of AD patients, implicating elevated brain iron levels, potentially via blood-brain barrier (BBB) breakdown, in disease pathophysiology [54].